Our aim was to determine serum hepcidin levels in patients with inflammatory bowel disease (IBD) as well to investigate whether there is a correlation of hepcidin levels with the disease activity in terms of whether hepcidin could be of use as a noninvasive marker of IBD activity. This evidence concerns the gene HAMP and inflammatory bowel disease.